| drug name | Vilanterol Fluticasone Propionate |
| classification | Combination inhaled corticosteroid and long-acting beta2-agonist (LABA) for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. |
| pharmacokinetics | Vilanterol, a long-acting beta2-agonist, is rapidly absorbed following inhalation. Fluticasone propionate, an inhaled corticosteroid, has a slower onset of action. Both are delivered directly to the lungs, minimizing systemic effects. Pharmacokinetic profiles may vary based on specific formulation and individual patient factors. |
| suggested dosage | Dosage is determined by a healthcare professional and depends on the specific formulation and the patient's individual needs. Adhere to the prescribed dosage and inhaler technique instructions provided by a healthcare professional. |
| indications | | 1 | | condition | Asthma (adults and children) | | details | Used as an add-on therapy to inhaled corticosteroids in patients who have not achieved adequate control on current medications. |
| | 2 | | condition | Chronic Obstructive Pulmonary Disease (COPD) | | details | Used to prevent exacerbations. |
|
|
| safety in pregnancy | Limited data available. Consult with a healthcare professional during pregnancy. Potential risks and benefits must be evaluated on a case-by-case basis. |
| safety in breastfeeding | Limited data. Consult a healthcare provider before use during breastfeeding. |
| side effects | | 1 | Cough | | 2 | Headache | | 3 | Pharyngolaryngeal irritation | | 4 | Oral candidiasis | | 5 | Upper respiratory infection | | 6 | Tremor | | 7 | Nervousness | | 8 | Muscle pain | | 9 | Hoarseness | | 10 | Increased heart rate | | 11 | Hypokalemia (low potassium levels) | | 12 | Hypertension (high blood pressure) | | 13 | Anxiety |
|
| alternatives | |
| contraindications | | 1 | Hypersensitivity or allergy to vilanterol, fluticasone propionate, or any components. | | 2 | Severe, uncontrolled cardiac conditions | | 3 | Uncontrolled or severe diabetes |
|
| interactions | Potential interactions with other medications and/or food exist. Inform your healthcare professional about all medications, supplements, and herbal remedies. This medication may affect the metabolism or efficacy of other medications, or vice versa. |
| warnings and precautions | | 1 | | condition | Cardiovascular disease, hyperthyroidism, or diabetes | | details | Close monitoring is required. |
| | 2 | | condition | Acute severe asthma attacks | | details | Avoid use during such attacks. |
| | 3 | | condition | Inhaler Technique | | details | Proper inhaler technique is critical to maximize drug delivery and minimize side effects. |
| | 4 | | condition | Adrenal Insufficiency | | details | Monitor patients closely for signs of adrenal insufficiency. |
|
|
| additional information | Inform your healthcare professional about any existing medical conditions or medications before using this drug. This is a maintenance therapy and should not be used on an as-needed basis. |
| patient information | |
| disclaimer | This information is for educational purposes only and does not constitute medical advice. Always seek the advice of a healthcare professional for any questions about your particular circumstances. |
